News|Articles|October 31, 2025
Navigating a Formulary Loss: How One Brand Protected Market Share
Author(s)CoverMyMeds
This case study explores how one pharmaceutical brand responded to a significant formulary loss, implementing seamless provider prior authorization strategies through CoverMyMeds to mitigate impact and maintain market share in a highly competitive class.
Newsletter
Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.
Related Content
Trending on PharmExec
1
Pharmaceutical Executive Daily: China Approves Amgen's Tarlatamab for Previously Treated Extensive-Stage Small Cell Lung Cancer
2
New Study Reveals Genetic Predictors for GLP-1 Weight Loss and Side Effects
3
Aradhana Sarin: The CFO as a Catalyst
4
Amgen’s Tarlatamab Approved in China
5